Evidence map›Paper›PMID 37521462›Full record

ArticleFrontiers in pharmacology2023

Renal mitochondrial restoration by gymnemic acid in gentamicin-mediated experimental nephrotoxicity: evidence from serum, kidney and histopathological alterations.

Shubhangi Gumbar, Sudeep Bhardwaj, Sidharth Mehan, Zuber Khan, Acharan S Narula, Reni Kalfin, Shams Tabrez, Torki A Zughaibi, Samina Wasi

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pharmacology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Evaluation of the protective role ofOpen veterinary journal · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 3 countries.

Shubhangi GumbarDepartment of Pharmacology, Seth G. L. Bihani S. D. College of Technical Education, Institute of Pharmaceutical Sciences and Drug Research, Sri Ganganagar, Rajasthan, India.
Sudeep BhardwajDepartment of Pharmacology, Seth G. L. Bihani S. D. College of Technical Education, Institute of Pharmaceutical Sciences and Drug Research, Sri Ganganagar, Rajasthan, India.
Sidharth MehanDepartment of Pharmacology, ISF College of Pharmacy (An Autonomous College), Moga, Punjab, India.
Zuber KhanDepartment of Pharmacology, ISF College of Pharmacy (An Autonomous College), Moga, Punjab, India.
Acharan S NarulaNarula Research, LLC, Chapel Hill, NC, United States.
Reni KalfinInstitute of Neurobiology, Bulgarian Academy of Sciences, Sofia, Bulgaria.
Shams TabrezKing Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Torki A ZughaibiKing Fahd Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia.
Samina WasiDepartment of Biochemistry, College of Medicine, Imam Abdulrahman Bin Faisal University, Alkhobar, Saudi Arabia.
Indo Soviet Friendship College of Pharmacy · INKing Abdulaziz University · SAImam Abdulrahman Bin Faisal University · SASouth-West University "Neofit Rilski" · BG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antioxidantgymnemic acidmitochondrial dysfunctionnephroprotectionnephrotoxicity

Identifiers

PMID37521462
PMCPMC10372487
OpenAlexW4384264247

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.